Literature DB >> 22401783

Rituximab: an effective treatment for rheumatologic and digestive symptoms of celiac disease?

Clémence Palazzo, Pascale Nicaise-Roland, Elisabeth Palazzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22401783     DOI： 10.1016/j.jbspin.2012.01.011

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  4 in total

Review 1.  Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens.

Authors:  Frits Koning; Ranjeny Thomas; Jamie Rossjohn; Rene E Toes
Journal:  Nat Rev Rheumatol       Date:  2015-05-19       Impact factor: 20.543

Review 2.  New Insights into the Pathogenesis of Celiac Disease.

Authors:  Valli De Re; Raffaella Magris; Renato Cannizzaro
Journal:  Front Med (Lausanne)       Date:  2017-08-31

3.  Rituximab treatment for dermatitis herpetiformis in the setting of type 1 diabetes mellitus, celiac disease, vitiligo, autoimmune hemolytic anemia, and autoimmune thrombocytopenia.

Authors:  Katarina T Nguyen; Courtney C Gwinn; Jay C Vary
Journal:  JAAD Case Rep       Date:  2020-01-22

4.  Gluten-specific antibodies of celiac disease gut plasma cells recognize long proteolytic fragments that typically harbor T-cell epitopes.

Authors:  Siri Dørum; Øyvind Steinsbø; Elin Bergseng; Magnus Ø Arntzen; Gustavo A de Souza; Ludvig M Sollid
Journal:  Sci Rep       Date:  2016-05-05       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.